Zdrowie i gospodarka · 18/01/2008

FDA Proposes Updates to Regulations for Human Cells, Tissues, and Cellular and Tissue-Based Products

The U.S. Food and Drug Administration (FDA) has issued a proposed rule to update its regulations for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/BTPs), which are used in various medical treatments and research. The proposed rule aims to modernize the agency's oversight of these products, which are derived from human sources and are used to develop new treatments for diseases.